M

Mainz Biomed BV
D

MYNZ

5.73000
USD
0.13
(2.32%)
مغلق
حجم التداول
3,494
الربح لكل سهم
-7
العائد الربحي
-
P/E
-0
حجم السوق
12,729,751
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Mainz Biomed N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.